http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2009203791-A1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_c999fee6428152a996011d506925c2d7
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-192
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-198
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-198
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-195
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-192
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P3-10
filingDate 2009-04-16-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3144573bef7944f1e16db0c31659fac1
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8d8650b8d8b27577c6f15c7b5e7f1786
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_81292b98fc5c54150d6d42909afc9515
publicationDate 2009-08-13-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber US-2009203791-A1
titleOfInvention Nateglinide-containing preparation
abstract The present invention discloses, as a immediate-release preparation useful as an antidiabetic, a nateglinide-containing preparation comprising nateglinide as an active ingredient wherein the nateglinide is amorphous.
priorityDate 2000-10-24-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2003073729-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5488150-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6641841-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2004029968-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2003229249-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6830759-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2004030182-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2003147951-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2004002544-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2004024219-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2003021843-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7022339-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6844008-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2006127475-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2004014815-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6296872-B1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6143323-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5463116-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7488498-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6559188-B1
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226393830
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5311309
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226393829
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID45051774
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226393819
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID31246
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226643980
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6251
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID107428
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID128797137
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226393946
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226413313
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3423265
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID128039798
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226411220
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226393714
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID11271
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226413312
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226393712
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID453
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID11177

Total number of triples: 59.